In vitro antifungal activity of aminosterols against moulds isolated from cystic fibrosis patients

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 6, 2010, Pages 1307-1309

  Alhanout, Kamel ^a   Brunel, Jean Michel ^a   Ranque, Stéphane ^a   Rolain, Jean Marc ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Antifungal agents; Filamentous fungi; Lung infections

Indexed keywords

AMINOSTEROL DERIVATIVE; AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; SQUALAMINE; UNCLASSIFIED DRUG; VORICONAZOLE;

ALTERNARIA; ALTERNARIA ALTERNATA; ALTERNARIA TRITICINA; ANTIFUNGAL ACTIVITY; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; ASPERGILLUS USTUS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CLADOSPORIUM; CLADOSPORIUM CLADOSPORIOIDES; CLADOSPORIUM CUCUMERINUM; CONTROLLED STUDY; CYSTIC FIBROSIS; EMERICELLA; EMERICELLA QUADRILINEATA; FUNGUS ISOLATION; FUSARIUM PROLIFERATUM; HUMAN; IN VITRO STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PENICILLIUM; PENICILLIUM GRISEOFULVUM; PETRIELLIDIUM BOYDII; RHIZOMUCOR; RHIZOMUCOR TAURICUS; RHIZOPUS ORYZAE; SCEDOSPORIUM; SCEDOSPORIUM APIOSPERMUM; SCEDOSPORIUM PROLIFERANS;

ANTIFUNGAL AGENTS; CHOLESTANOLS; CYSTIC FIBROSIS; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; FUNGI; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MYCOSES; SEQUENCE ANALYSIS, DNA;

EID: 77953554146     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq089     Document Type: Letter

References (6)

1. Alhanout K, Brunel JM, Raoult D et al. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis. J Antimicrob Chemother 2009; 64: 810-4.
2. Pihet M, Carrere J, Cimon B et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis-a review. Med Mycol 2009; 47: 387-97.
3. Qiao J, Liu W, Li R. Antifungal resistance mechanisms of Aspergillus. Nippon Ishinkin Gakkai Zasshi 2008; 49: 157-63.
4. Brunel JM, Salmi C, Loncle C et al. Squalamine: a polyvalent drug of the future? Curr Cancer Drug Targets 2005; 5: 267-72.
5. Cuenca-Estrella M, Gomez-Lopez A, Mellado E et al. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother 2006; 50: 917-21.
6. Verweij PE, Howard SJ, Melchers WJ et al. Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist Updat 2009; 12: 141-7.